News
Living Cell Technologies (ASX: LCT) has changed its name to Algorae Pharmaceuticals -1AI (ASX: 1AI).
Below are the previous articles from Living Cell Technologies (ASX: LCT):
RELATED STOCKHEAD STORIES
News
Closing Bell: Catch up footy leaves benchmark nibbling at parity for second straight session
Health & Biotech
Algorae, UNSW work on ‘revolutionary’ AI platform to accelerate drug discovery and development
News
Market Highlights: Wall Street’s late selloff, home prices rebound, and 5 ASX small caps to watch today
News
ASX Health Stocks: Living Cells Tech files a patent for cannabis-based dementia drug
Health & Biotech
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
Health & Biotech
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
Health & Biotech
Check Up: These 3 biotechs join the elite ASX 300 this week – and it could be a game-changer
News
Closing Bell: It’s trickle down economics… just not the kind you’re thinking of
Health & Biotech
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
Health & Biotech
ASX Health Stocks: Oneview extends software deal, LCT to start using AI technology
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
News
Reporting Season Round Up: Who shined on the ASX’s Judgement Day?
Health & Biotech
